Abstract:Background There is growing evidence of a strong relationship between COVID-19 and myocarditis. However, there are few bioinformatics-based analyses of critical genes and the mechanisms related to COVID-19 Myocarditis. This study aimed to identify critical genes related to COVID-19 Myocarditis by bioinformatic methods, explore the biological mechanisms and gene regulatory networks, and probe related drugs. Methods The gene expression data of GSE150392 and GSE167028 were obtained from the Gene Expression Omnibus (GEO), including cardiomyocytes derived from human induced pluripotent stem cells infected with SARS-CoV-2 in vitro and GSE150392 from patients with myocarditis infected with SARS-CoV-2 and the GSE167028 gene expression dataset. Differentially expressed genes (DEGs) (adjusted P-Value <0.01 and |Log2 Fold Change| ≥2) in GSE150392 were assessed by NetworkAnalyst 3.0. Meanwhile, significant modular genes in GSE167028 were identified by weighted gene correlation network analysis (WGCNA) and overlapped with DEGs to obtain common genes. Functional enrichment analyses were performed by using the "clusterProfiler" package in the R software, and protein-protein interaction (PPI) networks were constructed on the STRING website ( https://cn.string-db.org/ ). Critical genes were identified by the CytoHubba plugin of Cytoscape by 5 algorithms. Transcription factor-gene (TF-gene) and Transcription factor-microRibonucleic acid (TF-miRNA) coregulatory networks construction were performed by NetworkAnalyst 3.0 and displayed in Cytoscape. Finally, Drug Signatures Database (DSigDB) was used to probe drugs associated with COVID-19 Myocarditis. Results Totally 850 DEGs (including 449 up-regulated and 401 down-regulated genes) and 159 significant genes in turquoise modules were identified from GSE150392 and GSE167028, respectively. Functional enrichment analysis indicated that common genes were mainly enriched in biological processes such as cell cycle and ubiquitin-protein hydrolysis. 6 genes ( CDK1 , KIF20A , PBK , KIF2C , CDC20 , UBE2C ) were identified as critical genes. TF-gene interactions and TF-miRNA coregulatory network were constructed successfully. A total of 10 drugs, (such as Etoposide, Methotrexate, Troglitazone, etc) were considered as target drugs for COVID-19 Myocarditis. Conclusions Through bioinformatics method analysis, this study provides a new perspective to explore the pathogenesis, gene regulatory networks and provide drug compounds as a reference for COVID-19 Myocarditis. It is worth highlighting that critical genes ( CDK1 , KIF20A , PBK , KIF2C , CDC20 , UBE2C) may be potential biomarkers and treatment targets of COVID-19 Myocarditis for future study.

Exploration of Potential Biomarkers and Mechanisms for COVID-19 and Asthma Based on Microarray Analysis

Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid

Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks

Network-based analysis between SARS-CoV-2 receptor ACE2 and common host factors in COVID-19 and asthma: Potential mechanistic insights

Effect of SARS-CoV-2 infection on asthma patients

Uncovering Potential Key Genes Associated with the Pathogenesis of Asthma: A Microarray Analysis of Asthma-Relevant Tissues

Analysis of the potential molecular mechanisms of asthma and gastroesophageal reflux disease

Identification of candidate genes and molecular mechanisms related to asthma progression using bioinformatics

Dampening of Proteomics Activity Associated with the COVID-19 Patients Afflicted with Asthma based on Gene Expression Pattern

Bioinformatic analysis and preliminary validation of potential therapeutic targets for COVID-19 infection in asthma patients

Lipid Metabolism-Related Genes Are Involved in the Occurrence of Asthma and Regulate the Immune Microenvironment

Identification of shared potential diagnostic markers in asthma and depression through bioinformatics analysis and machine learning

Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients

Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19

Bioinformatics analyses of gene expression profile to identify pathogenic mechanisms for COVID-19 infection and cutaneous lupus erythematosus

Unraveling the molecular crosstalk and immune landscape between COVID-19 infections and ischemic heart failure comorbidity: New insights into diagnostic biomarkers and therapeutic approaches

Identification of Genes and Key Pathways Associated with the Pathophysiology of Lung Cancer and Atrial Fibrillation

Identification of critical genes and molecular pathways in COVID-19 myocarditis and constructing gene regulatory networks by bioinformatic analysis

Identification of common genes and pathways between type 2 diabetes and COVID-19

Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study

Identification of Key Genes and Regulatory Networks Involved in the Comorbidity of Atrial Fibrillation and Chronic Obstructive Pulmonary Disease